| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_460623a06500a41200438c92706fbb5e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12R2001-465 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1029
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P19-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-63 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-465 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63 |
| filingDate |
2011-07-21^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2015-06-20^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f27ed2e0eda4f57e21dcf1b6f804da5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1c15ad51dd82697cc7f6aa75ff3647d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a098f92f9e2fbacf756746c0db6be92a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_746474c149b4610d406d984c8cb62ee7 |
| publicationDate |
2015-06-20^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2553564-C2 |
| titleOfInvention |
Genetically modified bacterial strain wsj-ia i, producing isovaleryl spiramycin with high content and high output |
| abstract |
FIELD: chemistry. n SUBSTANCE: present invention relates to biotechnology and is a genetically modified strain of Streptomyces thermotolarences WSJ-IA, which produces isovaleryl spiramycin I. The present invention also discloses a method of producing said strain. The method includes steps of constructing a recombinant plasmid comprising a double gene ist-acyB2 and transforming the plasmid into the isovaleryl spiramycin I - producing strain WSJ-IA. The invention also discloses a method of producing isovaleryl spiramycin I by culturing the Streptomyces thermotolarences WSJ-IA strain in a culture medium. n EFFECT: present invention increases the output of the obtained isovaleryl spiramycin I. n 3 cl, 3 dwg, 5 tbl, 4 ex |
| priorityDate |
2010-07-23^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |